Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SAXENDA
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
- Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve Gastrectomy
- Is Saxenda® a Viable Treatment of Obese Patients in Forensic Psychiatry?
- Liraglutide for Low-responders After Bariatric Surgery
- Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
- Use of a GLP-1R Agonist to Treat Opioid Use Disorder
- Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet
- Effect of Liraglutide on Microbiome in Obesity
- To Predict Weight Loss Response to Liraglutide (Saxenda®), From fMRI-based Determination of Food Cue Reactivity
- Daily Liraglutide for Nicotine Dependence
- Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- The Effect of Liraglutide on Pancreatic Hormones and Its Size
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
- Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS
- Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
- Individualized Obesity Pharmacotherapy
- Reward Mechanisms in Obesity
- Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy
- Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- Impact of Liraglutide 3.0 on Body Fat Distribution
- Saxenda in Obesity Services (STRIVE Study)
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Saxenda: Underlying Mechanisms and Clinical Outcomes
- Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy
- Lifestyle Modification and Liraglutide
- Timely Detection of Treatment Emergent Serious and Non-serious Adverse Events for Saxenda® in Mexican Patients
- Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
- Improving Beta Cell Function in Mexican American Women With Prediabetes
Clinical trials list
click for details